Promotion of mesenchymal-to-epithelial transition by rac1 inhibition with small molecules accelerates hepatic differentiation of mesenchymal stromal cells

Nan Yuan Teng, Yi Shiuan Liu, Hao Hsiang Wu, Yu An Liu, Jennifer H. Ho, Oscar Kuang Sheng Lee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In vitro differentiation of stem cells into specific cell lineages provides a stable cell supply for cell therapy and tissue engineering. Therefore, understanding the mechanisms underlying such differentiation processes is critical for generating committed lineage-specific cell progenies effectively. We previously developed a two-step protocol to differentiate mesenchymal stromal cells (MSCs) into hepatocyte-like cells. Since hepatic differentiation involves mesenchymal-epithelial transition (MET), we hypothesize that promoting MET could further accelerate the differentiation process. Ras-related C3 botulinum toxin substrate 1 (Rac1) is involved in actin polymerization and its role in MET was investigated in the study. Our results showed that inhibition of Rac1 activation by Rac1-specific inhibitor, NSC23766, led to cells favoring epithelial morphology and being more packed during hepatic differentiation. In addition, Rac1 inhibition accelerated the upregulation of hepatic marker genes accompanied by more mature hepatic functions. Taken together, promotion of MET by inhibiting Rac1 accelerates the hepatic differentiation of MSCs. Our findings open a new prospect of directing the commitment of MSCs by manipulating cell morphology and cytoskeleton arrangement through small molecules. The results provide further insight into scaffold design for rapid production of MSC-differentiated hepatocytes.

Original languageEnglish
Pages (from-to)1444-1454
Number of pages11
JournalTissue Engineering - Part A
Volume21
Issue number7-8
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Epithelial-Mesenchymal Transition
Mesenchymal Stromal Cells
rac1 GTP-Binding Protein
Cells
Molecules
Liver
Stem cells
Tissue engineering
Scaffolds
Actins
Genes
Chemical activation
Polymerization
Hepatocytes
Cell Engineering
Substrates
Cell Lineage
Tissue Engineering
Cell- and Tissue-Based Therapy
Cytoskeleton

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry
  • Biomedical Engineering
  • Biomaterials

Cite this

Promotion of mesenchymal-to-epithelial transition by rac1 inhibition with small molecules accelerates hepatic differentiation of mesenchymal stromal cells. / Teng, Nan Yuan; Liu, Yi Shiuan; Wu, Hao Hsiang; Liu, Yu An; Ho, Jennifer H.; Lee, Oscar Kuang Sheng.

In: Tissue Engineering - Part A, Vol. 21, No. 7-8, 01.04.2015, p. 1444-1454.

Research output: Contribution to journalArticle

Teng, Nan Yuan ; Liu, Yi Shiuan ; Wu, Hao Hsiang ; Liu, Yu An ; Ho, Jennifer H. ; Lee, Oscar Kuang Sheng. / Promotion of mesenchymal-to-epithelial transition by rac1 inhibition with small molecules accelerates hepatic differentiation of mesenchymal stromal cells. In: Tissue Engineering - Part A. 2015 ; Vol. 21, No. 7-8. pp. 1444-1454.
@article{6166d08e1ddf41ab8536d5dbc3717857,
title = "Promotion of mesenchymal-to-epithelial transition by rac1 inhibition with small molecules accelerates hepatic differentiation of mesenchymal stromal cells",
abstract = "In vitro differentiation of stem cells into specific cell lineages provides a stable cell supply for cell therapy and tissue engineering. Therefore, understanding the mechanisms underlying such differentiation processes is critical for generating committed lineage-specific cell progenies effectively. We previously developed a two-step protocol to differentiate mesenchymal stromal cells (MSCs) into hepatocyte-like cells. Since hepatic differentiation involves mesenchymal-epithelial transition (MET), we hypothesize that promoting MET could further accelerate the differentiation process. Ras-related C3 botulinum toxin substrate 1 (Rac1) is involved in actin polymerization and its role in MET was investigated in the study. Our results showed that inhibition of Rac1 activation by Rac1-specific inhibitor, NSC23766, led to cells favoring epithelial morphology and being more packed during hepatic differentiation. In addition, Rac1 inhibition accelerated the upregulation of hepatic marker genes accompanied by more mature hepatic functions. Taken together, promotion of MET by inhibiting Rac1 accelerates the hepatic differentiation of MSCs. Our findings open a new prospect of directing the commitment of MSCs by manipulating cell morphology and cytoskeleton arrangement through small molecules. The results provide further insight into scaffold design for rapid production of MSC-differentiated hepatocytes.",
author = "Teng, {Nan Yuan} and Liu, {Yi Shiuan} and Wu, {Hao Hsiang} and Liu, {Yu An} and Ho, {Jennifer H.} and Lee, {Oscar Kuang Sheng}",
year = "2015",
month = "4",
day = "1",
doi = "10.1089/ten.tea.2014.0320",
language = "English",
volume = "21",
pages = "1444--1454",
journal = "Tissue Engineering - Part A.",
issn = "1937-3341",
publisher = "Mary Ann Liebert Inc.",
number = "7-8",

}

TY - JOUR

T1 - Promotion of mesenchymal-to-epithelial transition by rac1 inhibition with small molecules accelerates hepatic differentiation of mesenchymal stromal cells

AU - Teng, Nan Yuan

AU - Liu, Yi Shiuan

AU - Wu, Hao Hsiang

AU - Liu, Yu An

AU - Ho, Jennifer H.

AU - Lee, Oscar Kuang Sheng

PY - 2015/4/1

Y1 - 2015/4/1

N2 - In vitro differentiation of stem cells into specific cell lineages provides a stable cell supply for cell therapy and tissue engineering. Therefore, understanding the mechanisms underlying such differentiation processes is critical for generating committed lineage-specific cell progenies effectively. We previously developed a two-step protocol to differentiate mesenchymal stromal cells (MSCs) into hepatocyte-like cells. Since hepatic differentiation involves mesenchymal-epithelial transition (MET), we hypothesize that promoting MET could further accelerate the differentiation process. Ras-related C3 botulinum toxin substrate 1 (Rac1) is involved in actin polymerization and its role in MET was investigated in the study. Our results showed that inhibition of Rac1 activation by Rac1-specific inhibitor, NSC23766, led to cells favoring epithelial morphology and being more packed during hepatic differentiation. In addition, Rac1 inhibition accelerated the upregulation of hepatic marker genes accompanied by more mature hepatic functions. Taken together, promotion of MET by inhibiting Rac1 accelerates the hepatic differentiation of MSCs. Our findings open a new prospect of directing the commitment of MSCs by manipulating cell morphology and cytoskeleton arrangement through small molecules. The results provide further insight into scaffold design for rapid production of MSC-differentiated hepatocytes.

AB - In vitro differentiation of stem cells into specific cell lineages provides a stable cell supply for cell therapy and tissue engineering. Therefore, understanding the mechanisms underlying such differentiation processes is critical for generating committed lineage-specific cell progenies effectively. We previously developed a two-step protocol to differentiate mesenchymal stromal cells (MSCs) into hepatocyte-like cells. Since hepatic differentiation involves mesenchymal-epithelial transition (MET), we hypothesize that promoting MET could further accelerate the differentiation process. Ras-related C3 botulinum toxin substrate 1 (Rac1) is involved in actin polymerization and its role in MET was investigated in the study. Our results showed that inhibition of Rac1 activation by Rac1-specific inhibitor, NSC23766, led to cells favoring epithelial morphology and being more packed during hepatic differentiation. In addition, Rac1 inhibition accelerated the upregulation of hepatic marker genes accompanied by more mature hepatic functions. Taken together, promotion of MET by inhibiting Rac1 accelerates the hepatic differentiation of MSCs. Our findings open a new prospect of directing the commitment of MSCs by manipulating cell morphology and cytoskeleton arrangement through small molecules. The results provide further insight into scaffold design for rapid production of MSC-differentiated hepatocytes.

UR - http://www.scopus.com/inward/record.url?scp=84927615343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927615343&partnerID=8YFLogxK

U2 - 10.1089/ten.tea.2014.0320

DO - 10.1089/ten.tea.2014.0320

M3 - Article

VL - 21

SP - 1444

EP - 1454

JO - Tissue Engineering - Part A.

JF - Tissue Engineering - Part A.

SN - 1937-3341

IS - 7-8

ER -